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Those planning, managing and working in health systems worldwide routinely need to make decisions regarding
strategies to improve health care and promote equity. Systematic reviews of different kinds can be of great help to
these decision-makers, providing actionable evidence at every step in the decision-making process. Although there
is growing recognition of the importance of systematic reviews to inform both policy decisions and produce guidance
for health systems, a number of important methodological and evidence uptake challenges remain and better
coordination of existing initiatives is needed. The Alliance for Health Policy and Systems Research, housed within the
World Health Organization, convened an Advisory Group on Health Systems Research (HSR) Synthesis to bring together
different stakeholders interested in HSR synthesis and its use in decision-making processes. We describe the rationale
of the Advisory Group and the six areas of its work and reflects on its role in advancing the field of HSR synthesis.
We argue in favour of greater cross-institutional collaborations, as well as capacity strengthening in low- and
middle-income countries, to advance the science and practice of health systems research synthesis. We advocate for
the integration of quasi-experimental study designs in reviews of effectiveness of health systems intervention and
reforms. The Advisory Group also recommends adopting priority-setting approaches for HSR synthesis and increasing
the use of findings from systematic reviews in health policy and decision-making.
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Health policymakers and managers (henceforth decision-
makers), as well as other stakeholders (professional leaders,
civil society representatives) involved in health systems
worldwide, routinely face difficult decisions around improv-
ing health care and promoting equity. Ideally, decisions and
recommendations should be informed by the best available
research evidence, which typically comes from systematic
reviews of research [1–3]. Systematic reviews of health
systems evidence can be of great help to decision-makers,
providing actionable evidence at every step in the decision-
making process [4]. These steps require different types
of systematic reviews to address: (i) clarifying problems* Correspondence: langloise@who.int
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creativecommons.org/publicdomain/zero/1.0/and their causes; (ii) assessing potential policy and pro-
grammatic options, including their effectiveness; and
(iii) identifying implementation considerations (Table 1)
[5]. Systematic reviews are also valuable to identify priority
questions for new primary Health Systems Research (HSR).
The Alliance for Health Policy and Systems Research
(“Alliance”), a partnership housed within the World Health
Organization (WHO), is pioneering support for strengthen-
ing capacity for synthesis of health policy and systems
research through the establishment of systematic review
centres in low- and middle-income countries (LMICs).
The need for such a resource is especially acute in these
settings due to the limited capacity of individuals, teams,
organisations and knowledge systems to support the
production and use of systematic reviews [6]. To date, the
Alliance has supported centres in Bangladesh, Chile, China,
Lebanon, South Africa and Uganda. The focus of the cen-
tres is on reviews addressing questions of how to improvearticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Table 1 How systematic reviews can inform different steps in policy-making processes (adapted from Lavis 2009) [5]
Steps in policy-making Policy question Types of systematic reviews
Clarifying the problem
and its causes
Need for intervention: what is the nature, magnitude and
appropriate framing of the problem?
Reviews of observational and qualitative studies
Assessing potential
policy and programmatic
options
What is the appropriate set of options to address the problem and
what are the effects, cost-effectiveness and acceptability of these
options?
Reviews of effectiveness studies, economic
evaluations, studies of views and experiences,
process evaluations
Identifying What are the potential barriers to the successful implementation of
the options and potential windows of opportunity?
All of the above
Implementation
Considerations
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tematic reviews and review protocols have been produced
so far (for examples, see [7–13]).
The work of the Alliance centres complements that of
other recent global initiatives. The Evidence-Informed
Policy Network (EVIPNet) has actively promoted part-
nerships at the country level between policymakers, re-
searchers and civil society in order to facilitate both
policy development and policy implementation informed
by the best scientific evidence available [14]. Similarly,
the Task Force on Developing Health Systems Guidance,
convened by WHO, considered how evidence should be
translated into guidance to inform policies on health sys-
tems and improve the delivery of public health and health
systems interventions [1, 2, 15].
Although there is growing recognition of the importance
of systematic reviews to both inform policy decisions and
produce guidance for health systems, a number of import-
ant methodological challenges remain and there is a need
to better understand the processes supporting the trans-
parent use of review findings in complex health system
decisions. In addition, there is a multiplicity of initiatives
in the field and better coordination is needed. The Alli-
ance therefore convened an Advisory Group on Health
Systems Research Synthesis (“Advisory Group”) to bring
together different collaborations, groups and institutions
interested in HSR synthesis and its use in decision-making
processes [16].
In this paper, we outline the rationale of the Advisory
Group, the six areas of work steering its activities and
the guidance it provides to the Alliance and beyond; theTable 2 Evolution of the Advisory Group on Health Systems Researc
Date Location Activity
November 2009 Havana (Cuba) Organized Session during the
process on HSR synthesis coll
October 2010 London (UK) Ad Hoc Working Group on HS
Development (DFID) and reco
facilitate further discussions an
November 2010 Montreux (Switzerland) Session at the First Global Sym
recommendations to inform t
Currently Beijing, China
Cape Town, South Africa
Quarterly meetings of the Adv
Health Systems Research in Bepaper also reflects on challenges in producing complex
HSR syntheses and fostering their use in health systems
decision-making.Rationale for the advisory group
Since 2009, a series of consultative meetings led to the
development of recommendations to improve international
collaboration on HSR synthesis, with a focus on LMIC
needs and capacity building (Table 2). The consultations
focused on the following: (i) the benefits and challenges
associated with collaborative efforts to synthesise and
translate health systems evidence and (ii) the range of
approaches to evidence syntheses needed to address the
types of questions raised in decision-making processes for
strengthening health systems (Table 1).
The consultative meetings also revealed a landscape of
research synthesis in which the focus and activities of or-
ganisations varied in terms of the following: (1) content
(health systems or welfare practices and policies), (2)
research questions (e.g., effectiveness, views and experi-
ences), (3) geographical focus (high-income countries
(HIC) or LMIC)), and (4) capacity building (for supply
and/or demand for reviews). The Advisory Group was
established to play a central role in advancing the science
of HSR synthesis and knowledge translation by developing
and strengthening networks among individuals, groups,
institutions and collaborations that have an interest in
this field. Participating organisations include Cochrane
and The Campbell Collaboration, numerous academic
institutions and governmental and nongovernmentalh Synthesis
Global Forum for Health Research and initiation of a consultative
aboration
R Synthesis meeting at the UK Department for International
mmendation to establish an Advisory Group on HSR Synthesis to
d coordinate efforts
posium on Health Systems Research: development of a set of
he activities of the Advisory Group on HSR Synthesis
isory Group, including meetings alongside the Global Symposia on
ijing, China (2012) and Cape Town, South Africa (2014).
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and the International Initiative for Impact Evaluation (3ie)).
Discussion
Areas of work of the advisory group
Area 1 Advancing the science of HSR synthesis by
developing and strengthening networks between
individuals and institutions and collaborations and groups
that have an interest in HSR synthesis and translation
The Advisory Group has evolved to include participants
from 17 organizations/networks who convene once every
3 to 4 months to discuss current challenges and advances
related to both producing systematic reviews and drawing
on them for guidance on strengthening health systems.
The group shares information, identifies where further
methodological work or training is needed and builds
cross-institutional links, and thereby, with its anchoring
at the Alliance and WHO, serves as a global focal point
for coordination around the issues.
Area 2 Providing support, information sharing and
coordination related to setting priorities for HSR synthesis
regionally and globally and increasing capacity building
in HSR synthesis and translation (particularly in relation to
LMICs)
The Advisory Group, together with the Alliance more
broadly, has contributed to setting priorities for health
systems research on a global scale [17, 18]. The systematic
review centres funded by the Alliance have developed
priority-setting approaches for HSR syntheses and, in doing
so, have implemented different mechanisms to engage with
decision-makers, to increase the likelihood of the syn-
thesised evidence being applied in practice. For instance,
the South African Medical Research Council developed an
electronic survey addressed to both academics and practi-
tioners/policymakers, in order to identify key HSR issues
to be reviewed. Results of the survey informed a preselec-
tion phase in which existing systematic reviews relevant to
the HSR issues identified were summarised. This process
informed the ranking of a set of the highest priority ques-
tions by a steering committee and advisory group, which
included policymakers at national and regional levels.
Another example is the Center for Systematic Reviews
of Health Policy and Systems Research (SPARK) at the
American University of Beirut in Lebanon, which is devel-
oping a tool for prioritizing questions for HSR systematic
reviews. Although priority-setting approaches exist for
some types of research [19, 20], little work addresses how
to engage policymakers and other stakeholders in priori-
tizing research [21] and there is no published framework
to guide priority setting for health policy and systems
research synthesis.
Limited capacity and issues of financial sustainability
of groups in LMICs that undertake systematic reviews arefurther important challenges identified by the Advisory
Group. For example, how can these groups secure core
funding, ensure the availability of specialised resources
such as information scientist support and statistical tools,
strengthen their capacity to undertake the wide range
of reviews needed to inform health system decisions
and improve their engagement with decision-makers in
the review process? Discussions on these issues contributed
to the development of the new Global Evidence Synthesis
Initiative (GESI), led by an international collaborating
group of organisations1 and convened by Cochrane. It is
anticipated that GESI will coordinate and support the de-
velopment of capacities for conducting systematic reviews
(not necessarily limited to health systems evidence or even
the health sector) in LMICs, building on the resources
and networks of the collaborating organisations.
Another important challenge identified by the Advisory
Group relates to strengthening the capacity of decision-
makers and stakeholders to access, assess and apply HSR
evidence in decision-making and to create a “user-pull”
for HSR evidence. The Advisory Group advocates for and
supports the development of user-friendly summaries of
HSR syntheses and recognises the importance of
sensitization workshops for users of HSR syntheses, insti-
tutionalised mechanisms for researcher-user interactions
and knowledge translation activities. The last involves
using knowledge translation tools such as evidence briefs
for policy and briefing notes and convening dialogue ses-
sions with decision-makers and stakeholders.
Area 3 Expanding the range of study designs that can be
included in reviews of the effectiveness of HSR interventions
For a number of areas within the field of HSR, evidence
from quasi-experimental studies forms a substantive
component of the overall evidence base for questions
on the impacts of interventions. Evidence from quasi-
experimental studies may be particularly important for
reviews of interventions or exposures whose effects are not,
often for practical reasons, easily amenable to measurement
using designs based on random assignment of participants
or facilities to comparison groups under the direct control
of researchers. Quasi-experimental studies, such as regres-
sion discontinuity designs, [22, 23] interrupted time series
[24] and instrumental variable analyses [25], offer po-
tential for inferences to be made about the causal effects
of health systems interventions and reforms. These infer-
ences can be as valid as those derived from randomised
controlled trials—without intervening externally in the
health system. Quasi-experimental studies thus allow
the study of intervention and reform effectiveness in their
natural setting.
However, efforts to integrate quasi-experimental studies
into effectiveness review frameworks in both HICs and
LMICs are, in general, at an early stage of development
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incorporating evidence from quasi-experimental studies are
underdeveloped for most fields of study, including HSR
[29]. Review authors therefore do not always include these
study designs when it might be appropriate to do so. For in-
stance, two recent studies of systematic reviews of health
systems evidence found wide variation in their inclusion of
quasi-experimental studies and suggested that more work
is needed on when it may be useful to do so [29, 30].
With the Harvard School of Public Health, the Alliance
organized a workshop in 2013 focused on the following:
(1) establishing a taxonomy of quasi-experimental study
designs, (2) developing guidelines for systematic review
authors on incorporating quasi-experimental studies in
reviews, (3) devising strategies to build institutional capacity
to support the wider inclusion of quasi-experimental stud-
ies in reviews, (4) establishing approaches to translate evi-
dence from quasi-experimental studies for policymakers,
and (5) strengthening partnerships between researchers in
HICs and researchers in LMICs.
One of the outputs of the workshop and the background
work commissioned by the Alliance is the identification of
five quasi-experimental study designs frequently employed
in health systems research: natural experiments, instru-
mental variable analyses, regression discontinuity analyses,
interrupted times series studies and difference studies
including controlled before-and-after designs, difference-
in-difference designs and fixed effects analyses of panel
data [31].Area 4 Piloting a system for producing policy relevant
syntheses/systematic reviews of HSR addressing questions
other than effectiveness
Systematic reviews addressing the full range of health
system issues may be useful for decision-making (Table 1).
However, guidance around syntheses for questions other
than effectiveness of interventions remains limited. Fur-
ther guidance is needed on templates for reporting results,
tools to assess confidence in review results and institu-
tional mechanisms to facilitate evidence uptake.
The EPPI Centre is leading a study, funded by the Alli-
ance, on supporting policy-relevant systematic reviews
for health systems. Interviews with policymakers and
systematic reviewers have emphasised the importance of
connecting these two groups and supporting their mutual
engagement with formalised procedures and structures,
so as to ensure that their motivations for producing and
using systematic reviews are aligned in terms of the urgency
and generalizability of products [32].
In addition, members of the Advisory Group are con-
ducting scoping reviews to assess the most appropriate
knowledge synthesis methods to answer different types ofresearch questions [33, 34]. These reviews aim to identify,
define and classify emerging knowledge synthesis methods.
Area 5 Advocating for and supporting a common global
database for all types of systematic reviews of HSR
The Advisory Group acknowledges the utility and pro-
motes the use of repositories of evidence synthesis in
this field, such as Health Systems Evidence (HSE)
(www.healthsystemsevidence.org), a database for all types
of systematic reviews of HSR. In this database, systematic
reviews, and links to their included primary studies, are
complemented by a range of other policy-relevant doc-
uments addressing health systems, including evidence
briefs for policymakers, overviews of systematic reviews,
systematic review protocols, economic evaluations and
descriptions of health system reforms. The database is
available in Arabic, Chinese, English, French, Portuguese,
Russian and Spanish; it can be searched using country,
region and LMIC filters; it includes links to user-friendly
summaries written by other groups. These features make
the database a particularly powerful resource for health sys-
tem decision-makers, stakeholders and researchers. HSE
also now includes the beta version for an Intergovern-
mental Organizations’ Health Systems Documents Portal,
developed as a complete inventory of all policy-relevant
WHO documents about health systems. Another useful
repository is PDQ-Evidence (http://www.pdq-evidence.org),
which links systematic reviews of HSR and other health
research, overviews of reviews and their included pri-
mary studies.
These databases are useful in identifying existing reviews
that could inform decisions on specific HSR issues and
should also be consulted at the planning stages for new
primary health system research and for reviews. This
would allow identification of gaps in the HSR literature
and key areas for further HSR, including implementation
research (Table 1).
Area 6 Advocating for and supporting prospective
registration of all protocols for systematic reviews when
they are planned
Prospective registration of systematic reviews is an im-
portant step in reducing duplication of effort, fostering
collaboration on conducting reviews and enabling com-
parison of the completed review with what was planned
originally. International prospective register of systematic
reviews (PROSPERO), the international prospective register
of systematic reviews (http://www.crd.york.ac.uk/prospero),
was established for this purpose but initially included only
reviews of effectiveness. The Advisory Group therefore
initiated discussions with PROSPERO regarding how the
full range of health systems systematic reviews (Table 1)
could be accommodated. This feedback, as well as findings
from a survey of users [35], led to modifications to provide
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Conclusion
The Advisory Group continues to identify and address
key challenges faced by those undertaking HSR synthe-
sis, including issues relevant to strengthening dialogue
and collaboration between producers and users of evi-
dence syntheses, as well as the uptake of findings from
these reviews. A number of challenges remain in produ-
cing and using HSR evidence synthesis in relation to (i)
the research domain, for instance human and financial
resource constraints for conducting reviews and limited
open access to and functionality of databases; (ii) the
policy domain, including limited access to HSR systematic
reviews and difficulties in assessing both how well evidence
syntheses were conducted and how much confidence to
have in their findings; and (iii) optimising the linkages be-
tween these domains to foster the uptake of findings into
policy-making, for instance the alignment of review ques-
tions with policy needs and timeliness in the production
and uptake of HSR synthesis.
Further work of the Advisory Group aims to address
these challenges, including capacity development and
methods development across these domains. Ongoing
work by members of the Advisory Group includes devel-
oping norms and standards for qualitative and mixed-
methods reviews, building on existing resources [36, 37]
and designing approaches to assess how much confidence
to place in evidence from different types of health systems
research synthesis. For example, a team of methodologists
is developing a tool to assess how much confidence to
place in evidence from reviews of qualitative research (the
CERQual tool) [38, 39].
We argue that early engagement with decision-makers
is critical for prioritizing, planning and conducting HSR
systematic reviews and for enhancing the relevance and
uptake of review findings. In engaging with decision-
makers, special attention should be given to the challenge
of translating priority policy issues into reviewable HSR
questions. Funders of initiatives to strengthen health sys-
tems are also a key target audience of the Advisory Group.
When designing and funding such initiatives in LMICs,
we would suggest that funders take into consideration
both available policy-relevant HSR syntheses and the need
to build capacity for HSR synthesis.
Those conducting reviews should give more consider-
ation, when it is appropriate to do so, to evidence from
quasi-experimental studies on the impacts of health systems
interventions. Following from this, further development of
the methods and standards for incorporating quasi-
experimental evidence into reviews is needed. Complemen-
tary to developing standards for reviewing is the work of
the EQUATOR (Enhancing the QUAlity and TransparencyOf health Research) initiative, which seeks to improve the
reliability and value of health research by promoting trans-
parent and accurate reporting of studies and reviews [40].
Given the complexity of health systems’ decision-making
processes, we also need to undertake systematic reviews ad-
dressing the full range of HSR issues, including questions
other than the effectiveness of health system interventions.
Overall, the focus on collaborative priority setting for
research, judicious choice of study designs and relying
on systematic reviews rather than single studies for making
decisions about health systems set this work alongside the
movement advocating less waste and greater value in bio-
medical research [41, 42]. We argue that greater cross-
institutional collaboration is needed to advance the science
and practice of health systems research synthesis. Users of
HSR syntheses also need to be assisted in developing their
awareness and ability to identify, assess and use review find-
ings in health systems decision-making.
These efforts need continued collaboration and co-
ordination across different organizations, networks and
actors. We believe a coordination mechanism like the
Advisory Group can fulfil the need for aligning interests,
methods and approaches and for securing interest and in-
vestments in the field of health systems research synthesis
globally.
More information on the activities of the Advisory
Group is available at http://www.who.int/alliance-hpsr/
projects/hsrsynthesis/en/index.html
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